Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Surgical Endoscopy
Erschienen in: Surgical Endoscopy 4/2012

01.04.2012 | Review

Diabetic and bariatric surgery: A review of the recent trends

verfasst von: Raghavendra S. Rao, Subhash Kini

Erschienen in: Surgical Endoscopy | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Bariatric surgery is currently the most effective treatment for diabetes associated with morbid obesity.

Methods

A Pubmed search was made for all articles on bariatric surgery and diabetes from 2009 to present (March 2011) in order to identify the recent advances in this field. Herein we review the recent data available on the long-term effects of bariatric surgery on diabetes. We also review the efficacy of gastrointestinal surgery done for diabetic patients having body mass index (BMI) <35 kg/m2 and also the effect of novel bariatric procedures on diabetes associated with obesity. Finally, the efficacy of bariatric surgery in adolescent diabetes and the recent epidemiological trends of type 2 diabetes are also dealt with briefly.

Conclusion

RYGB and biliopancreatic diversion (BPD) are effective surgical options for diabetes in the long term (>5 yrs). The efficacy of sleeve gastrectomy on diabetes in the long term is not yet known. Gastrointestinal procedures for non morbidly obese and non obese patients have shown great promise as surgical optional for diabetes, though their efficacy and safety in the long term are unknown. Novel endoscopic techniques and TANTALUS have shown some promise in resolving diabetes in obese patients. Bariatric surgery is very effective is resolving adolescent diabetes.
Literatur
1.
Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–484PubMed
2.
3.
Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961–969PubMedCrossRef
4.
Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–241PubMedCrossRef
5.
6.
7.
Residori L, Garcia-Lorda P, Flancbaum L, Pi-Sunyer FX, Laferrere B (2003) Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race. Obes Surg 13:333–340PubMedCrossRef
8.
Brufani C, Ciampalini P, Grossi A, Fiori R, Fintini D, Tozzi A, Cappa M, Barbetti F (2010) Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy. Pediatr Diabetes 11:47–54PubMedCrossRef
9.
Felszeghy E, Juhasz E, Kaposzta R, Ilyes I (2008) Alterations of glucoregulation in childhood obesity—association with insulin resistance and hyperinsulinemia. J Pediatr Endocrinol Metab 21:847–853PubMed
10.
Patriti A, Facchiano E, Annetti C, Aisa MC, Galli F, Fanelli C, Donini A (2005) Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg 15:1258–1264PubMedCrossRef
11.
Wang TT, Hu SY, Gao HD, Zhang GY, Liu CZ, Feng JB, Frezza EE (2008) Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 247:968–975PubMedCrossRef
12.
Boza C, Gagner M, Devaud N, Escalona A, Munoz R, Gandarillas M (2008) Laparoscopic sleeve gastrectomy with ileal transposition (SGIT): a new surgical procedure as effective as gastric bypass for weight control in a porcine model. Surg Endosc 22:1029–1034PubMedCrossRef
13.
DePaula AL, Stival AR, DePaula CC, Halpern A, Vencio S (2010) Impact on dyslipidemia of the laparoscopic ileal interposition associated to sleeve gastrectomy in type 2 diabetic patients. J Gastrointest Surg 14:1319–1325PubMedCrossRef
14.
DePaula AL, Macedo AL, Rassi N, Machado CA, Schraibman V, Silva LQ, Halpern A (2008) Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 22:706–716PubMedCrossRef
15.
De Paula AL, Stival AR, Macedo A, Ribamar J, Mancini M, Halpern A, Vencio S (2010) Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21–34 kg/m(2). Surg Obes Relat Dis 6:296–304PubMedCrossRef
16.
DePaula AL, Macedo AL, Schraibman V, Mota BR, Vencio S (2009) Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20–34. Surg Endosc 23:1724–1732PubMedCrossRef
17.
Depaula AL, Stival AR, Halpern A, Vencio S (2010) Surgical treatment of morbid obesity: mid-term outcomes of the laparoscopic ileal interposition associated to a sleeve gastrectomy in 120 patients. Obes Surg 21(5):668–675CrossRef
18.
Kumar KV, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P, Modi KD (2009) Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther 11:785–789PubMedCrossRef
19.
Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244:741–749PubMedCrossRef
20.
Speck M, Cho YM, Asadi A, Rubino F, Kieffer TJ (2011) Duodenal-jejunal bypass protects GK rats from beta-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells co-expressing GIP and GLP-1. Am J Physiol Endocrinol Metab 300(5):E923–E932PubMedCrossRef
21.
Cohen RV, Schiavon CA, Pinheiro JS, Correa JL, Rubino F (2007) Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–34 kg/m2: a report of 2 cases. Surg Obes Relat Dis 3:195–197PubMedCrossRef
22.
Lee HC, Kim MK, Kwon HS, Kim E, Song KH (2010) Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients. Obes Surg 20:1530–1535PubMedCrossRef
23.
Navarrete SA, Leyba JL, Llopis SN (2011) Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients: technique and preliminary results. Obes Surg 21(5):663–667PubMedCrossRef
24.
Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ, Chen JC, Chen CM (2010) Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 147:664–669PubMedCrossRef
25.
Shah SS, Todkar JS, Shah PS, Cummings DE (2010) Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m2. Surg Obes Relat Dis 6:332–338PubMedCrossRef
26.
Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Fried M, Briatore L, D’alessandro G, Andraghetti G, Cordera R (2011) Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg 253:699–703PubMedCrossRef
27.
Frenken M, Cho EY, Karcz WK, Grueneberger J, Kuesters S (2011) Improvement of type 2 diabetes mellitus in obese and non-obese patients after the duodenal switch operation. J Obes 2011:860169PubMed
28.
Rubino F, Kaplan LM, Schauer PR, Cummings DE (2010) The diabetes surgery summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 251:399–405PubMedCrossRef
29.
Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, de Ramon RA, Israel G, Dolezal JM (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–350PubMedCrossRef
30.
Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256PubMedCrossRef
31.
Higa K, Ho T, Tercero F, Yunus T, Boone KB (2010) Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up. Surg Obes Relat Dis 16(6):1151–1152
32.
Sugerman HJ, Wolfe LG, Sica DA, Clore JN (2003) Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237:751–756PubMed
33.
van de Weijgert EJ, Ruseler CH, Elte JW (1999) Long-term follow-up after gastric surgery for morbid obesity: preoperative weight loss improves the long-term control of morbid obesity after vertical banded gastroplasty. Obes Surg 9:426–432PubMedCrossRef
34.
MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ (1997) The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1:213–220PubMedCrossRef
35.
Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693PubMedCrossRef
36.
Cunneen SA (2008) Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding. Surg Obes Relat Dis 4:S47–S55PubMedCrossRef
37.
Cunneen SA, Phillips E, Fielding G, Banel D, Estok R, Fahrbach K, Sledge I (2008) Studies of Swedish adjustable gastric band and lap-band: systematic review and meta-analysis. Surg Obes Relat Dis 4:174–185PubMedCrossRef
38.
Schouten R, Wiryasaputra DC, van Dielen FM, van Gemert WG, Greve JW (2010) Long-term results of bariatric restrictive procedures: a prospective study. Obes Surg 20:1617–1626PubMedCrossRef
39.
Himpens J, Cadiere GB, Bazi M, Vouche M, Cadiere B, Dapri G (2011) Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg 146(7):802–807PubMedCrossRef
40.
Karcz WK, Krawczykowski D, Kuesters S, Marjanovic G, Kulemann B, Grobe H, Karcz-Socha I, Hopt UT, Bukhari W, Grueneberger JM (2011) Influence of sleeve gastrectomy on NASH and type 2 diabetes mellitus. J Obes 2011:765473PubMed
41.
Cottam D, Qureshi FG, Mattar SG, Sharma S, Holover S, Bonanomi G, Ramanathan R, Schauer P (2006) Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 20:859–863PubMedCrossRef
42.
Srinivasa S, Hill LS, Sammour T, Hill AG, Babor R, Rahman H (2010) Early and mid-term outcomes of single-stage laparoscopic sleeve gastrectomy. Obes Surg 20:1484–1490PubMedCrossRef
43.
Basso N, Casella G, Rizzello M, Abbatini F, Soricelli E, Alessandri G, Maglio C, Fantini A (2011) Laparoscopic sleeve gastrectomy as first stage or definitive intent in 300 consecutive cases. Surg Endosc 25:444–449PubMedCrossRef
44.
Sammour T, Hill AG, Singh P, Ranasinghe A, Babor R, Rahman H (2010) Laparoscopic sleeve gastrectomy as a single-stage bariatric procedure. Obes Surg 20:271–275PubMedCrossRef
45.
Lakdawala MA, Bhasker A, Mulchandani D, Goel S, Jain S (2010) Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study. Obes Surg 20:1–6PubMedCrossRef
46.
Chowbey PK, Dhawan K, Khullar R, Sharma A, Soni V, Baijal M, Mittal T (2010) Laparoscopic sleeve gastrectomy: an Indian experience-surgical technique and early results. Obes Surg 20:1340–1347PubMedCrossRef
47.
Shah PS, Todkar JS, Shah SS (2010) Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis 6:138–141PubMedCrossRef
48.
Jacobs M, Bisland W, Gomez E, Plasencia G, Mederos R, Celaya C, Fogel R (2010) Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results. Surg Endosc 24:781–785PubMedCrossRef
49.
Silecchia G, Boru C, Pecchia A, Rizzello M, Casella G, Leonetti F, Basso N (2006) Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg 16:1138–1144PubMedCrossRef
50.
Rice RD, Simon TE, Seery JM, Frizzi JD, Husain FA, Choi YU (2010) Laparoscopic sleeve gastrectomy: outcomes at a military training center. Am Surg 76:835–840PubMed
51.
Magee CJ, Barry J, Arumugasamy M, Javed S, Macadam R, Kerrigan DD (2010) Laparoscopic sleeve gastrectomy for high-risk patients: weight loss and comorbidity improvement-short-term results. Obes Surg 6(3):322–325CrossRef
52.
Nienhuijs SW, de Zoete JP, Berende CA, de H I, Smulders JF (2010) Evaluation of laparoscopic sleeve gastrectomy on weight loss and co-morbidity. Int J Surg 8:302–304PubMedCrossRef
53.
Gan SS, Talbot ML, Jorgensen JO (2007) Efficacy of surgery in the management of obesity-related type 2 diabetes mellitus. ANZ J Surg 77:958–962PubMedCrossRef
54.
Moon HS, Kim WW, Oh JH (2005) Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg 15:1469–1475CrossRef
55.
Rosenthal R, Li X, Samuel S, Martinez P, Zheng C (2009) Effect of sleeve gastrectomy on patients with diabetes mellitus. Surg Obes Relat Dis 5:429–434PubMedCrossRef
56.
Vidal J, Ibarzabal A, Nicolau J, Vidov M, Delgado S, Martinez G, Balust J, Morinigo R, Lacy A (2007) Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg 17:1069–1074PubMedCrossRef
57.
de Gordejuela AG, Pujol GJ, Garcia NV, Alsina EF, Medayo LS, Masdevall NC (2011) Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients? Surg Obes Relat Dis 7(4):506–509PubMedCrossRef
58.
Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC, Tsai MH, Chuang LM (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146:143–148PubMedCrossRef
59.
Peterli R, Wolnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Court, Drewe J, von FM, Beglinger C (2009) Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 250:234–241PubMedCrossRef
60.
Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N (2010) Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 24:1005–1010PubMedCrossRef
61.
Todkar JS, Shah SS, Shah PS, Gangwani J (2010) Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus. Surg Obes Relat Dis 6:142–145PubMedCrossRef
62.
D’Hondt M, Vanneste S, Pottel H, Devriendt D, Van RF, Vansteenkiste F (2011) Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc 25(8):2498–2504PubMedCrossRef
63.
Gill RS, Birch DW, Shi X, Sharma AM, Karmali S (2010) Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis 6:707–713PubMedCrossRef
64.
Hess DS, Hess DW, Oakley RS (2005) The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg 15:408–416PubMedCrossRef
65.
Marceau P, Biron S, Hould FS, Lebel S, Marceau S, Lescelleur O, Biertho L, Simard S (2007) Duodenal switch: long-term results. Obes Surg 17:1421–1430PubMedCrossRef
66.
Larrad-Jimenez A, az-Guerra CS, de Cuadros BP, Lesmes IB, Esteban BM (2007) Short-, mid- and long-term results of Larrad biliopancreatic diversion. Obes Surg 17:202–210PubMedCrossRef
67.
Crea N, Pata G, Di BE, Greco F, Casella C, Vilardi A, Mittempergher F (2011) Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity. Obes Surg 21:139–145PubMedCrossRef
68.
Iaconelli A, Panunzi S, De GA, Manco M, Guidone C, Leccesi L, Gniuli D, Nanni G, Castagneto M, Ghirlanda G, Mingrone G (2011) Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 34:561–567PubMedCrossRef
69.
Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF (2005) Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 28:2406–2411PubMedCrossRef
70.
Scopinaro N (2006) Biliopancreatic diversion: mechanisms of action and long-term results. Obes Surg 16:683–689PubMedCrossRef
71.
Aguirre V, Stylopoulos N, Grinbaum R, Kaplan LM (2008) An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring) 16:2585–2592CrossRef
72.
Rodriguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, Tarnoff M (2008) First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 4:55–59PubMedCrossRef
73.
Escalona A, Becerra P, Gabrielli M, Turiel D, Awruch D, Pimentel F, Sharp A, Ibanez L, Galvao M, Bambs C (2010) One-year study of weight loss and metabolic syndrome improvement resulting from use of the endoscopic duodenal-jejunal bypass liner. Abstract presented at IFSO 2010
74.
Escalona A, Yanez R, Pimentel F, Galvao M, Ramos AC, Turiel D, Boza C, Awruch D, Gersin K, Ibanez L (2010) Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity. Surg Obes Relat Dis 6:126–131PubMedCrossRef
75.
Tarnoff M, Rodriguez L, Escalona A, Ramos A, Neto M, Alamo M, Reyes E, Pimentel F, Ibanez L (2009) Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc 23:650–656PubMedCrossRef
76.
Rodriguez L, Reyes E, Fagalde P, Oltra MS, Saba J, Aylwin CG, Prieto C, Ramos A, Galvao M, Gersin KS, Sorli C (2009) Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther 11:725–732PubMedCrossRef
77.
Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM, Greve JW (2010) A multicenter, randomized efficacy study of the endobarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery. Ann Surg 251:236–243PubMedCrossRef
78.
79.
Doldi SB, Micheletto G, Perrini MN, Librenti MC, Rella S (2002) Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg 12:583–587PubMedCrossRef
80.
Crea N, Pata G, Della CD, Minelli L, Maifredi G, Di BE, Mittempergher F (2009) Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg 19:1084–1088PubMedCrossRef
81.
Mui WL, Ng EK, Tsung BY, Lam CH, Yung MY (2010) Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg 20:1128–1132PubMedCrossRef
82.
Donadio F, Sburlati LF, Masserini B, Lunati EM, Lattuada E, Zappa MA, Mozzi E, Beck-Peccoz P, Orsi E (2009) Metabolic parameters after bioenterics intragastric balloon placement in obese patients. J Endocrinol Invest 32:165–168PubMed
83.
Ricci G, Bersani G, Rossi A, Pigo F, De FG, Alvisi V (2008) Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. Obes Surg 18:1438–1442PubMedCrossRef
84.
Deviere J, Ojeda VG, Cuevas HL, Closset J, Le MO, Eisendrath P, Moreno C, Dugardeyn S, Barea M, de la TR, Edmundowicz S, Scott S (2008) Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg Endosc 22:589–598PubMedCrossRef
85.
Chiellini C, Iaconelli A, Familiari P, Riccioni ME, Castagneto M, Nanni G, Costamagna G, Mingrone G (2010) Study of the effects of transoral gastroplasty on insulin sensitivity and secretion in obese subjects. Nutr Metab Cardiovasc Dis 20:202–207PubMedCrossRef
86.
Brethauer SA, Chand B, Schauer PR, Thompson CC (2010) Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients. Surg Obes Relat Dis 6:689–694PubMedCrossRef
87.
Fogel R, De FJ, Bonilla Y, De La FR (2008) Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc 68:51–58PubMedCrossRef
88.
Sanmiguel CP, Conklin JL, Cunneen SA, Barnett P, Phillips EH, Kipnes M, Pilcher J, Soffer EE (2009) Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control. J Diabetes Sci Technol 3:964–970PubMed
89.
Bohdjalian A, Prager G, Rosak C, Weiner R, Jung R, Schramm M, Aviv R, Schindler K, Haddad W, Rosenthal N, Ludvik B (2009) Improvement in glycemic control in morbidly obese type 2 diabetic subjects by gastric stimulation. Obes Surg 19:1221–1227PubMedCrossRef
90.
Bohdjalian A, Ludvik B, Guerci B, Bresler L, Renard E, Nocca D, Karnieli E, Assalia A, Prager R, Prager G (2009) Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes. Surg Endosc 23:1955–1960PubMedCrossRef
91.
Bohdjalian A, Prager G, Aviv R, Policker S, Schindler K, Kretschmer S, Riener R, Zacherl J, Ludvik B (2006) One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Obes Surg 16:627–634PubMedCrossRef
92.
Policker S, Haddad W, Yaniv I (2009) Treatment of type 2 diabetes using meal-triggered gastric electrical stimulation. Isr Med Assoc J 11:206–208PubMed
93.
Policker S, Lu H, Haddad W, Aviv R, Kliger A, Glasberg O, Goode P (2008) Electrical stimulation of the gut for the treatment of type 2 diabetes: the role of automatic eating detection. J Diabetes Sci Technol 2:906–912PubMed
94.
Andersson S, Ringstrom G, Elfvin A, Simren M, Lonroth H, Abrahamsson H (2011) Temporary percutaneous gastric electrical stimulation: a novel technique tested in patients with non-established indications for gastric electrical stimulation. Digestion 83:3–12PubMedCrossRef
95.
Inge TH, Miyano G, Bean J, Helmrath M, Courcoulas A, Harmon CM, Chen MK, Wilson K, Daniels SR, Garcia VF, Brandt ML, Dolan LM (2009) Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics 123:214–222PubMedCrossRef
96.
97.
Al-Qahtani AR (2007) Laparoscopic adjustable gastric banding in adolescent: safety and efficacy. J Pediatr Surg 42:894–897PubMedCrossRef
98.
Holterman AX, Browne A, Dillard BE III, Tussing L, Gorodner V, Stahl C, Browne N, Labott S, Herdegen J, Guzman G, Rink A, Nwaffo I, Galvani C, Horgan S, Holterman M (2007) Short-term outcome in the first 10 morbidly obese adolescent patients in the FDA-approved trial for laparoscopic adjustable gastric banding. J Pediatr Gastroenterol Nutr 45:465–473PubMedCrossRef
99.
Holterman AX, Browne A, Tussing L, Gomez S, Phipps A, Browne N, Stahl C, Holterman MJ (2010) A prospective trial for laparoscopic adjustable gastric banding in morbidly obese adolescents: an interim report of weight loss, metabolic and quality of life outcomes. J Pediatr Surg 45:74–78PubMedCrossRef
100.
O’Brien PE, Sawyer SM, Laurie C, Brown WA, Skinner S, Veit F, Paul E, Burton PR, McGrice M, Anderson M, Dixon JB (2010) Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA 303:519–526PubMedCrossRef
101.
Till H, Bluher S, Hirsch W, Kiess W (2008) Efficacy of laparoscopic sleeve gastrectomy (LSG) as a stand-alone technique for children with morbid obesity. Obes Surg 18:1047–1049PubMedCrossRef
102.
Papadia FS, Adami GF, Marinari GM, Camerini G, Scopinaro N (2007) Bariatric surgery in adolescents: a long-term follow-up study. Surg Obes Relat Dis 3:465–468PubMedCrossRef
103.
Sugerman HJ, Sugerman EL, DeMaria EJ, Kellum JM, Kennedy C, Mowery Y, Wolfe LG (2003) Bariatric surgery for severely obese adolescents. J Gastrointest Surg 7:102–107PubMedCrossRef
Metadaten
Titel
Diabetic and bariatric surgery: A review of the recent trends
verfasst von
Raghavendra S. Rao
Subhash Kini
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 4/2012
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-011-1976-7

Weitere Artikel der Ausgabe 4/2012

Surgical Endoscopy 4/2012 Zur Ausgabe

OriginalPaper

Radio-guided thoracoscopic surgery (RGTS) of small pulmonary nodules

OriginalPaper

Laparoendoscopic single-site surgery versus conventional laparoscopic varicocele ligation in men with palpable varicocele: A randomized, clinical study

OriginalPaper

Qualitative and quantitative analysis of women’s perceptions of transvaginal surgery

OriginalPaper

A comparative study of multiport versus laparoendoscopic single-site adrenalectomy for benign adrenal tumors

OriginalPaper

Comprehensive evaluation of endoscopic fundoplication using the EsophyXTM device

OriginalPaper

Effect of haptic feedback in laparoscopic surgery skill acquisition

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.
Bildnachweise